Absolute cardiovascular risk of women using hormonal contraception in Porto-Novo.

Simple item page
AuteurSONOU, ARNAUD
AuteurOGOUDJOBI, OGOURINDE MATHIEU
AuteurADJAGBA, MAHOUNA PHILIPPE DOTOU
Date d'ajout2026-06-02T16:06:57Z
Date de disponibilite2026-06-02T16:06:57Z
Date de publication2018
ResumeIntroduction: The purpose of this work was to determine the absolute cardiovascular risk (ACVR) of women using hormonal contraception in Porto-Novo. Methods: We carried out a descriptive, cross-sectional study, including women at the time of renewal of a hormonal contraceptive method. Blood pressure, fasting venous blood glucose level, body mass index and electrocardiographic left ventricular hypertrophy were studied. The determination of ACVR was dual based on the World Health Organisation (WHO/ISH) and the European Society of Cardiology (ESC/ ESH) models. Results: The mean age of the women was 35.3 ± 8.2 years. Blood pressure and blood glucose levels were high in 24 and 1.5% of cases, respectively. Left ventricular hypertrophy was present in 7.1% of cases. A high ACVR was found in 5.2% of these women, using the ESC/ESH model. Conclusion: The occurrence of women with high ACVR in this group raises the problem of cardiovascular eligibility to the contraceptive method used.
DOI10.5830/CVJA-2018-016
Autre identifiantBECDB-7479
URIhttps://dspace.uac.bj/handle/123456789/6735
Languefr
Fait partie deCardiovascular Africa Journal of Africa.
Sujetabsolute cardiovascular risk
SujetHormonal contraception
Sujeteligibility
TitreAbsolute cardiovascular risk of women using hormonal contraception in Porto-Novo.
TypeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
bcb89742bc7225a3bd7d11e1e6d8596a.pdf
Size:
61.38 KB
Format:
Adobe Portable Document Format
Download

Collections

Articles